Dachaigh › Luchd-obrach › Canaccord Genuity LLC
Canaccord Genuity LLC: Tuarastalan H-1B agus taic bhìosa
Chuir Canaccord Genuity LLC 22 iarrtasan cumha-obrach a-steach airson bhìosaichean H-1B agus bhìosaichean co-cheangailte ann am bliadhnaichean ionmhais 2023–2026; le teisteanas: 22. Tuarastal meadhanach a chaidh a thabhann: $135,000.
A bheil Canaccord Genuity LLC a’ toirt taic do bhìosaichean H-1B?
Chuir Canaccord Genuity LLC 22 iarrtasan cumha-obrach a-steach ann am bliadhnaichean ionmhais 2023–2026, an tè as ùire air a chur a-steach air 13 Cèit 2026. Is e LCA a’ chiad cheum ann an iarrtas H-1B, mar sin tha an neach-fastaidh air taic a thoirt do luchd-obrach H-1B no air ullachadh airson sin a dhèanamh; cha gharantaich e taic airson dreuchd shònraichte sam bith. Thoir sùil air liostaichean obrach an neach-fastaidh fhèin.
Tuarastalan a rèir tiotal obrach
| Tiotal dreuchd | LCAs | Tuarastal meadhanach |
|---|---|---|
| Investment Banking Analyst | 3 | $100,000 |
| Associate, Australian Desk Salesperson | 2 | $110,000 |
| Banking Analyst 1 | 2 | $100,000 |
| Director, Investment Banking | 1 | $250,000 |
| Senior Research Associate (Biotechnology) | 1 | $135,000 |
| Analyst (2nd Year) | 1 | $105,000 |
| Analyst (3rd Year) | 1 | $120,000 |
| Director, Australian Equities | 1 | $175,000 |
| Director, Salesperson | 1 | $120,000 |
| Vice President - Australian Product Sales | 1 | $145,000 |
| Australian Institutional Equity Sales (Americas) | 1 | $188,880 |
| Banking Analyst 2 | 1 | $110,000 |
| Second Year Banking Associate | 1 | $180,000 |
| Vice President, Biotechnology Equity Research | 1 | $150,000 |
| Managing Director, Australian Equity Sales Manager | 1 | $175,000 |
| Managing Director, Australian Equity Sales - Americas | 1 | $175,000 |
| Investment Banking Associate 2 | 1 | $180,000 |
| VP, Biotechnology Equity Research | 1 | $150,000 |
Iarrtasan a rèir bliadhna ionmhais
| Bliadhna mhaoine | LCAs | Tuarastal meadhanach |
|---|---|---|
| FY2023 | 9 | $110,000 |
| FY2024 | 2 | $147,500 |
| FY2025 | 7 | $145,000 |
| FY2026 | 4 | $175,000 |
Ìrean tuarastail làithreach
Suidhichidh Roinn an Obrach ceithir ìrean tuarastail làithreach airson gach dreuchd agus sgìre, bho Ìre I (inntrigeadh) gu Ìre IV (gu tur comasach). Taghaidh an neach-fastaidh an ìre a fhreagras ri riatanasan na h-obrach.
Far a bheil na h-obraichean
Dreuchdan
- Financial and Investment Analysts10
- Securities, Commodities, and Financial Services Sales Agents8
- Statisticians3
- Financial Managers1
Iarrtasan as ùire
| Tiotal dreuchd | Tuarastal bunasach | Àite | Air a chur a-steach | Ceann-latha tòiseachaidh | Inbhe |
|---|---|---|---|---|---|
| VP, Biotechnology Equity Research | $150,000 Ìre III | New York, NY | 13 Cèit 2026 | 1 Dàmh 2026 | Dearbhaichte |
| Investment Banking Associate 2 | $180,000 Ìre IV | New York, NY | 21 Gibl 2026 | 1 Dàmh 2026 | Dearbhaichte |
| Managing Director, Australian Equity Sales - Americas | $175,000 Ìre II | New York, NY | 21 Gibl 2026 | 1 Dàmh 2026 | Dearbhaichte |
| Managing Director, Australian Equity Sales Manager | $175,000 E-3 · Ìre II | New York, NY | 5 Samh 2025 | 1 Dùbh 2025 | Dearbhaichte |
| Second Year Banking Associate | $180,000 Ìre III | New York, NY | 19 Lùna 2025 | 8 Sult 2025 | Dearbhaichte |
| Vice President, Biotechnology Equity Research | $150,000 Ìre III | New York, NY | 8 Iuch 2025 | 1 Dàmh 2025 | Dearbhaichte |
| Banking Analyst 1 | $100,000 Ìre I | New York, NY | 8 Gibl 2025 | 1 Dàmh 2025 | Dearbhaichte |
| Banking Analyst 1 | $100,000 Ìre I | New York, NY | 8 Gibl 2025 | 1 Dàmh 2025 | Dearbhaichte, an uair sin air a tharraing air ais |
| Banking Analyst 2 | $110,000 Ìre I | New York, NY | 8 Gibl 2025 | 1 Dàmh 2025 | Dearbhaichte |
| Australian Institutional Equity Sales (Americas) | $188,880 E-3 · Ìre II | New York, NY | 8 Faoi 2025 | 1 Màrt 2025 | Dearbhaichte |
| Vice President - Australian Product Sales | $145,000 E-3 · Ìre II | New York, NY | 26 Sult 2024 | 1 Dùbh 2024 | Dearbhaichte |
| Director, Australian Equities | $175,000 E-3 · Ìre III | New York, NY | 26 Sult 2023 | 1 Dùbh 2023 | Dearbhaichte |
| Director, Salesperson | $120,000 H-1B1 (Sile) · Ìre III | Miami, FL | 26 Sult 2023 | 1 Dùbh 2023 | Dearbhaichte |
| Senior Research Associate (Biotechnology) | $135,000 Ìre III | New York, NY | 12 Ògmh 2023 | 31 Lùna 2023 | Dearbhaichte |
| Investment Banking Analyst | $100,000 Ìre I | New York, NY | 20 Màrt 2023 | 2 Sult 2023 | Dearbhaichte, an uair sin air a tharraing air ais |
| Investment Banking Analyst | $135,000 Ìre I | New York, NY | 16 Màrt 2023 | 23 Lùna 2023 | Dearbhaichte |
| Investment Banking Analyst | $100,000 Ìre I | New York, NY | 7 Màrt 2023 | 20 Lùna 2023 | Dearbhaichte, an uair sin air a tharraing air ais |
| Associate, Australian Desk Salesperson | $110,000 E-3 · Ìre I | New York, NY | 6 Màrt 2023 | 1 Gibl 2023 | Dearbhaichte |
| Associate, Australian Desk Salesperson | $110,000 Ìre I | New York, NY | 6 Màrt 2023 | 20 Lùna 2023 | Dearbhaichte |
| Analyst (3rd Year) | $120,000 Ìre II | New York, NY | 6 Cèit 2022 | 31 Cèit 2022 | Dearbhaichte, an uair sin air a tharraing air ais |
| Director, Investment Banking | $250,000 Ìre II | New York, NY | 3 Màrt 2022 | 1 Ògmh 2022 | Dearbhaichte, an uair sin air a tharraing air ais |
| Analyst (2nd Year) | $105,000 Ìre II | Boston, MA | 5 Samh 2021 | 29 Samh 2021 | Dearbhaichte, an uair sin air a tharraing air ais |
Is e na tuarastalan an ìre as ìsle den tuarastal a chaidh a thabhann air gach iarrtas, air an tionndadh gu suim bhliadhnail; cleachdaidh na staitistigean iarrtasan làn-aimsire le teisteanas a-mhàin. Chan eil LCA na aontachadh bhìosa agus faodaidh aon LCA còmhdach a dhèanamh air iomadh dreuchd. Stòr: Roinn an Obrach na SA, Dàta Foillseachaidh OFLC LCA, bliadhnaichean ionmhais 2023–2026 (co-dhùnadh as ùire 30 Ògmh 2026).